Catheter Precision Inc (VTAK) Projected Price to Earnings

The forward P/E chart for Catheter Precision (VTAK) demonstrates the market valuation of the asset, where the value of 0.00 corresponds to the current metric. Diversification of delivery routes and warehouse reserves in the US ensure the stability of system assembly. Demand for cardiology treatment remains independent of economic crises. Catheter Precision (VTAK) benefits from VIVO technology, which enables precise heart mapping without invasive incisions.

VTAK - catheterprecision.com Future Price to Earnings Multiple over the range 02/21/2024 - 10/05/2026

Comprehensive metric breakdowns and analytics for Catheter Precision Corporation (VTAK)

- stock quotes and analyst forecast:

Stock Price Catheter Precision, Inc.|VTAK - Analyst Consensus Forecast

- market capitalization details:

Market Valuation Catheter Precision Inc|VTAK - Aggregate Business Value

- issuer book value statistics:

Book Value per Share Catheter Precision|VTAK - Accounting Value of Company|Market Capitalization to Book Value Ratio catheterprecision.com|VTAK - Company Assets

- debt and solvency information:

Total Debt to Equity Ratio Catheter Precision|VTAK - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Catheter Precision|VTAK - Company Cumulative Debt|Debt to Book Capitalization Ratio Catheter Precision Inc|VTAK - Company Long-Term Loans and Borrowings|Company Current Liabilities Catheter Precision|Quick Liquidity catheterprecision.com

- earnings and market ratios statistics:

VTAK - Profit After Tax|Expected Profit Catheter Precision|VTAK - Company Value to Net Income|Forward P/E Multiple Catheter Precision Corp|VTAK - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Catheter Precision Inc|VTAK - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Catheter Precision|VTAK - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months catheterprecision.com|VTAK - Expected net earnings per share growth this year|Earnings growth forecast for next year Catheter Precision

Analysis of all company metrics:VTAK Catheter Precision, Inc.

Product sample of Catheter Precision Corporation

The forward P/E ratio relates the current market value of Catheter Precision (VTAK) to its projected net income, allowing investors to determine the premium paid for the asset through the lens of expected earnings. By analyzing the company's expected P/E valuation, one can assess the extent to which market optimism is justified by the technological leadership of Catheter Precision (VTAK) in AI-powered vascular imaging and robotics for arrhythmia treatment.

Direct competitors

Forward P/E Multiple REGN|Forward P/E Multiple iRhythm Technologies, Inc. (IRTC)|Lantheus Medical Imaging - Projected Price to Earnings|Market Cap to Future Earnings Ratio MLYS (Mineralys Corp)|HeartFlow, Inc. - Forward P/E Multiple|Future Price to Earnings Multiple KMTS (kestramedical.com)|ESPR: Forward P/E Multiple|Projected Price to Earnings Ratio Amarin Corporation (AMRN)|Projected Price to Earnings AVR|TNYA (Tenaya Therapeutics Inc) - Market Cap to Future Earnings Ratio|Forward P/E Multiple CVRX|MIST - Projected Price to Earnings Ratio|Future Price to Earnings Cardiol Therapeutics Inc. CRDL|Future Price to Earnings Multiple BEAT|TENX: Projected Price to Earnings|Future Price to Earnings Multiple ADGM (Adagio Medical, Inc.)|BioCardia, Inc. (BCDA) - Future Price to Earnings|Price to Expected Earnings Ratio ABIO (ARCA Biopharma, Inc.)|Future Price to Earnings Acasti Pharma Inc|AVTE: Future Price to Earnings Multiple|Forward P/E Multiple VERV|WINT - Projected Price to Earnings Ratio